Ikarian Capital’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-400,000
Closed -$4.37M 265
2021
Q2
$4.37M Hold
400,000
0.35% 75
2021
Q1
$4.4M Hold
400,000
0.15% 130
2020
Q4
$4.24M Hold
400,000
0.19% 104
2020
Q3
$4.22M Hold
400,000
0.31% 75
2020
Q2
$4.2M Buy
+400,000
New +$4.02M 0.33% 73

Ikarian Capital's CHAQ.U Position: Q3 2021 in Review

Ikarian Capital sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q3 2021, closing a stake of 400,000 shares — an estimated $4.37M sold.

Ikarian Capital first reported a position in CHAQ.U in Q2 2020 and held it in 5 quarters. The position peaked at $4.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.U as of Q3 2021.

  • Ikarian Capital reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q3 2021 after selling out during the quarter.
  • Ikarian Capital sold 400,000 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q3 2021, an estimated $4.37M.
  • Ikarian Capital first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q2 2020 and held it in 5 quarters.
  • Ikarian Capital's Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $4.4M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q3 2021.

Based on Ikarian Capital's 13F filing for Q3 2021, filed 15 Nov 2021.